Skip to main content
. 2014 Apr 22;9(4):e95736. doi: 10.1371/journal.pone.0095736

Figure 3. Adjusted* cumulative probabilities for ascites development.

Figure 3

(A) Cumulative probabilities of ascites according to different cutoffs of MAP†. (B) Cumulative probabilities of ascites based on the use of nonselective β-blockers. (C) Cumulative probabilities of ascites according to different cutoffs of MAP* in a subgroup of patients without antihypertensive drug therapy. * Adjusting covariates for MAP were gender, presence of varices, antihypertensive drugs (diuretics, ACE inhibitor and calcium antagonist), NSBB for portal hypertension, bilirubin, AST/ALT ratio, creatinine, albumin, platelets, INR for prothrombin time, and serum sodium, and for NSBB were the same including MAP. † Four groups of approximately equal size were created by MAP (quartiles labeled MAP>100.31 mm/Hg, MAP between 93.32 and 100.31 mm/Hg, MAP between 83.32 and 93.32, and MAP<83.32 mm/Hg). Abbreviations: MAP, mean arterial pressure; NSBB, nonselective β-blockers.